1. Habibzadeh P, Stoneman EK. The Novel Coronavirus: A Bird’s Eye View. Int J Occup Environ Med. 2020;11(2): 65–71. doi:10.15171/ijoem.2020.1921

2. Su S, Wong G, Shi W, Liu J, Lai ACK, Zhou J, Liu W, Bi Y, Gao GF. Epidemiology, Genetic Recombination, and Pathogenesis of Coronaviruses. Trends Microbiol. 2016;24(6): 490–502. doi:10.1016/j.tim.2016.03.003

3. Seah I, Agrawal R. Can the Coronavirus Disease 2019 (COVID-19) Affect the Eyes? A Review of Coronaviruses and Ocular Implications in Humans and Animals. Ocul Immunol Inflamm. 2020;28(3): 391–395. doi:10.1080/09273948.2020.1738501

4. World Health Organization. Origin of SARSCoV- 2, 26 March 2020. World Health Organization. 2020. Available from: https://extranet.who.int/iris/restricted/

5. bitstream/handle/10665/332197/WHO-2019-nCoVFAQ-Virus_origin-2020.1-eng.pdf [Accessed 26 June 2020].

6. She J, Jiang J, Ye L, Hu L, Bai C, Song Y. 2019 novel coronavirus of pneumonia in Wuhan, China: emerging attack and management strategies. Clin Transl Med. 2020;9(1): 19. doi:10.1186/s40169-020-00271-z

7. Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19). 16-24 February 2020. World Health Organization; 2020. Available from: https://www.who.int/docs/default-source/coronaviruse/who-china-joint-mission-on-covid-19-final-report.pdf [Accessed 26 June 2020].

8. Chan JF, Kok KH, Zhu Z, Chu H, To KK, Yuan S, Yuen KY. Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerg Microbes Infect. 2020;9(1): 221–236. doi:10.1080/22221751.2020.1719902

9. Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, Wang W, Song H, Huang B, Zhu N, Bi Y, Ma X, Zhan F, Wang L, Hu T, Zhou H, Hu Z, Zhou W, Zhao L, Chen J, Meng Y, Wang J, Lin Y, Yuan J, Xie Z, Ma J, Liu WJ, Wang D, Xu W, Holmes EC, Gao GF, Wu G, Chen W, Shi W, Tan W. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020;395(10224): 565–574. doi:10.1016/S0140-6736(20)30251-8

10. Zhou L, Xu Z, Castiglione GM, Soiberman US, Eberhart CG, Duh EJ. ACE2 and TMPRSS2 are expressed on the human ocular surface, suggesting susceptibility to SARS-CoV-2 infection. Ocul Surf. 2020;18(4): 537–544. doi:10.1016/j.jtos.2020.06.007

11. Jiang RD, Liu MQ, Chen Y, Shan C, Zhou YW, Shen XR, Li Q, Zhang L, Zhu Y, Si HR, Wang Q, Min J, Wang X, Zhang W, Li B, Zhang HJ, Baric RS, Zhou P, Yang XL, Shi ZL. Pathogenesis of SARS-CoV-2 in Transgenic Mice Expressing Human Angiotensin-Converting Enzyme 2. Cell. 2020;S0092-8674(20): 30622-X. doi:10.1016/j.cell.2020.05.027

12. Всемирная организация здравоохранения. Лабораторное тестирование при подозрении на заражение человека новым коронавирусом 2019 г. (2019-nCoV). Временные рекомендации 17 января 2020 г. Всемирная организация здравоохранения. 2020. Доступно по: https://apps.who.int/iris/bitstream/handle/10665/330676/9789240001053-rus.pdf [Ссыл- ка активна на 26.06.2020]. [Vsemirnaya organizatsiya zdravookhraneniya. Laboratornoe testirovanie pri podozrenii na zarazhenie cheloveka novym koronavirusom 2019. (2019-nCoV). Vremennye rekomendatsii 17.01.2020. Vsemirnaya organizatsiya zdravookhraneniya. 2020: 8. Available from: https://apps.who.int/iris/bitstream/handle/10665/330676/9789240001053-rus.pdf [Accessed 26 June 2020]. (In Russ.)]

13. Wang X, Zhong M, Liu Y, Ma P, Dang L, Meng Q, Wan W, Ma X, Liu J, Yang G, Yang Z, Huang X, Liu M. Rapid and Sensitive Detection of COVID-19 Using CRISPR/Cas12a-based Detection with Naked Eye Readout, CRISPR/Cas12a-NER. Sci Bull (Beijing). 2020. doi:10.1016/j.scib.2020.04.041

14. Moitra P, Alafeef M, Dighe K, Frieman MB, Pan D. Selective Naked-Eye Detection of SARS-CoV-2 Mediated by N Gene Targeted Antisense Oligonucleotide Capped Plasmonic Nanoparticles. ACS Nano. 2020;14(6): 7617–7627. doi:10.1021/acsnano.0c03822

15. Grajewski RS, Rokohl AC, Becker M, Dewald F, Lehmann C, Fätkenheuer G, Cursiefen C, Klein F, Heindl LM. A missing link between SARS-CoV-2 and the eye? ACE2 expression on the ocular surface. J Med Virol. 2020. doi:10.1002/jmv.26136

16. van der Hoek L, Pyrc K, Jebbink MF, Vermeulen- Oost W, Berkhout RJ, Wolthers KC, Wertheim-van Dillen PM, Kaandorp J, Spaargaren J, Berkhout B. Identification of a new human coronavirus. Nat Med. 2004;10(4): 368–373. doi:10.1038/nm1024

17. Vabret A, Mourez T, Dina J, van der Hoek L, Gouarin S, Petitjean J, Brouard J, Freymuth F. Human coronavirus NL63, France. Emerg Infect Dis. 2005;11(8): 1225–1229. doi:10.3201/eid1108.050110

18. Loon SC, Teoh SC, Oon LL, Se-Thoe SY, Ling AE, Leo YS, Leong HN. The severe acute respiratory syndrome coronavirus in tears. Br J Ophthalmol. 2004;88(7): 861–863. doi:10.1136/bjo.2003.035931

19. Chan WM, Yuen KS, Fan DS, Lam DS, Chan PK, Sung JJ. Tears and conjunctival scrapings for coronavirus in patients with SARS. Br J Ophthalmol. 2004;88(7): 968–969. doi:10.1136/bjo.2003.039461

20. Yan A. Chinese expert who came down with Wuhan coronavirus after saying it was controllable thinks he was infected through his eyes. China: South China Morning Post. 2020. Available from: https://www.scmp.com/news/china/article/3047394/chineseexpert-who-came-down-wuhan-coronavirus-aftersaying-it-was [Accessed 26 June 2020].

21. Lai THT, Tang EWH, Chau SKY, Fung KSC, Li KKW. Stepping up infection control measures in ophthalmology during the novel coronavirus outbreak: an experience from Hong Kong. Graefes Arch Clin Exp Ophthalmol. 2020;258(5): 1049–1055. doi:10.1007/s00417-020-04641-8

22. Lu CW, Liu XF, Jia ZF. 2019-nCoV transmission through the ocular surface must not be ignored. Lancet. 2020;395(10224): e39. doi:10.1016/S0140-6736(20)30313-5

23. Li JO, Lam DSC, Chen Y, Ting DSW. Novel Coronavirus disease 2019 (COVID-19): The importance of recognising possible early ocular manifestation and using protective eyewear. Br J Ophthalmol. 2020;104(3): 297–278. doi:10.1136/bjophthalmol-2020-315994

24. Xia J, Tong J, Liu M, Shen Y, Guo D. Evaluation of coronavirus in tears and conjunctival secretions of patients with SARS-CoV-2 infection. J Med Virol. 2020;92(6): 589–594. doi:10.1002/jmv.25725

25. Vaninov N. In the eye of the COVID-19 cytokine storm. Nat Rev Immunol. 2020;20(5): 277. doi:10.1038/s41577-020-0305-6

26. Seah IYJ, Anderson DE, Kang AEZ, Wang L, Rao P, Young BE, Lye DC, Agrawal R. Assessing Viral Shedding and Infectivity of Tears in Coronavirus Disease 2019 (COVID-19) Patients. Ophthalmology. 2020;127(7): 977–979. doi:10.1016/j.ophtha.2020.03.026

27. Seitzman GD, Doan T. No Time for Tears. Ophthalmology. 2020;127(7): 980–981. doi:10.1016/j.ophtha.2020.03.030

28. Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, Liu L, Shan H, Lei CL, Hui DSC, Du B, Li LJ, Zeng G, Yuen KY, Chen RC, Tang CL, Wang T, Chen PY, Xiang J, Li SY, Wang JL, Liang ZJ, Peng YX, Wei L, Liu Y, Hu YH, Peng P, Wang JM, Liu JY, Chen Z, Li G, Zheng ZJ, Qiu SQ, Luo J, Ye CJ, Zhu SY, Zhong NS; China Medical Treatment Expert Group for Covid-19. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020;382(18): 1708–1720. doi:10.1056/NEJMoa2002032

29. Wu P, Duan F, Luo C, Liu Q, Qu X, Liang L, Wu K. Characteristics of Ocular Findings of Patients With Coronavirus Disease 2019 (COVID-19) in Hubei Province, China. JAMA Ophthalmol. 2020;138(5): 575–578. doi:10.1001/jamaophthalmol.2020.1291

30. Choudhary R, Kapoor MS, Singh A, Bodakhe SH. Therapeutic targets of renin-angiotensin system in ocular disorders. J Curr Ophthalmol. 2016;29(1): 7–16. doi:10.1016/j.joco.2016.09.009

31. Dockery DM, Rowe SG, Murphy MA, Krzystolik MG. The Ocular Manifestations and Transmission of COVID-19: Recommendations for Prevention. J Emerg Med. 2020;S0736-4679(20): 30398-X. doi:10.1016/j.jemermed.2020.04.060

32. Zhou Y, Zeng Y, Tong Y, Chen C. Ophthalmologic evidence against the interpersonal transmission of 2019 novel coronavirus through conjunctiva. MedRxiv. 2020. doi:10.1101/2020.02.11.20021956

33. Sun X, Zhang X, Chen X, Chen L, Deng C, Zou X, Liu W, Yu H. The infection evidence of SARS-CoV-2 in ocular surface: a single-center cross-sectional study. MedRxiv. 2020. doi:10.1101/2020.02.26.20027938

34. Chen L, Liu M, Zhang Z, Qiao K, Huang T, Chen M, Xin N, Huang Z, Liu L, Zhang G, Wang J. Ocular manifestations of a hospitalised patient with confirmed 2019 novel coronavirus disease. Br J Ophthalmol. 2020;104(6): 748–751. doi:10.1136/bjophthalmol-2020-316304

35. Colavita F, Lapa D, Carletti F, Lalle E, Bordi L, Marsella P, Nicastri E, Bevilacqua N, Giancola ML, Corpolongo A, Ippolito G, Capobianchi MR, Castilletti C. SARS-CoV-2 Isolation From Ocular Secretions of a Patient With COVID-19 in Italy With Prolonged Viral RNA Detection. Ann Intern Med. 2020;M20: 1176. doi:10.7326/M20-1176

36. Hu Y, Chen T, Liu M, Zhang L, Wang F, Zhao S, Liu H, Xia H, Wang Y, Li L. Positive detection of SARSCoV- 2 combined HSV1 and HHV6B virus nucleic acid in tear and conjunctival secretions of a non-conjunctivitis COVID-19 patient with obstruction of common lacrimal duct. Acta Ophthalmol. 2020. doi:10.1111/aos.14456

37. Chen L, Deng C, Chen X, Zhang X, Chen B, Yu H, Qin Y, Xiao K, Zhang H, Sun X. Ocular manifestations and clinical characteristics of 534 cases of COVID- 19 in China: A cross-sectional study. MedRxIV. 2020. doi:10.1101/2020.03.12.20034678

38. Министерство здравоохранения Российской Федерации. Временные методические рекомендации. Профилактика, диагностика и лечение новой коронавирусной инфекции (COVID-19). Версия 7 (03.06.2020). 2020: 165. Доступно по: https://static-0.rosminzdrav.ru/system/attachments/attaches/000/050/584/original/03062020_%D0%9CR_

39. COVID-19_v7.pdf [Ссылка активна на: 26.06.2020]. [Ministry of health of the Russian Federation. Temporary guidelines. Рrevention, diagnosis and treatment of new coronavirus infection (COVID-19). Version 7 (03.06.2020). 2020: 165. Available from: https://static-0.rosminzdrav.ru/system/attachments/attaches/000/050/584/original/03062020_%D0%9CR_COVID-19_v7.pdf [Accessed 26 June 2020]. (In Russ.)]

40. van Doremalen N, Bushmaker T, Morris DH, Holbrook MG, Gamble A, Williamson BN, Tamin A, Harcourt JL, Thornburg NJ, Gerber SI, Lloyd-Smith JO, de Wit E, Munster VJ. Aerosol and Surface Stability of SARSCoV- 2 as Compared with SARS-CoV-1. N Engl J Med. 2020;382(16): 1564–1567. doi:10.1056/NEJMc2004973

41. American Academy of Ophthalmology. Alert: Important coronavirus updates for ophthalmologists. Available from: https://www.aao.org/headline/alertimportant-coronavirus-context [Accessed 26 June 2020].

42. Коронавирус. Памятка для офтальмологов. Доступно по: https://oor.ru/files/novosti/pamyatka_po_koronavirusu.pdf [Ссылка активна на: 26.06.2020]. [Koronavirus. Pamyatka dlya oftal’mologov. Available from: https://oor.ru/files/novosti/pamyatka_po_koronavirusu.pdf [Accessed 26 June 2020]. (In Russ.)]

43. Мусаев-Галбинур П.И., Акберова С.И, Гусева Т.С., Паршина О.В., Тазулахова Э.Б., Мамедова В.М. Влияние Актипола на уровень интерферона в слезной жидкости (клинико-лабораторные исследования). Вестник Офтальмологии. 2001;117(6): 33–35. [Musaev Galbinur PI, Akberova SI, Guseva TS, Parshina OV, Tazulakhova EB, Mamedova VM. Vliyanie aktipola na uroven’ interferona v sleznoi zhidkosti (klinikolaboratornye issledovaniya). Vestnik Oftal’mologii. 2001;117(6): 33–35. (In Russ.)]

44. Акберова С.И., Тазулахова Э.Б., Мусаев-Галбинур П.И., Мамедова В.М. Влияние парааминобензойной кислоты (Актипол) на продукцию интерлейкина-6 у больных с герпетическими кератитами. Вестник Офтальмологии. 2006;122(5): 23–26. [Vliyanie para-aminobenzoinoi kisloty (Aktipol®) na produktsiyu interleikina-6 u bol’nykh s gerpeticheskimi keratitami. Vestnik Oftal’mologii. 2006;122 (5): 23–26. (In Russ.)]

45. Shmueli O, Chowers I, Levy J. Current safety preferences for intravitreal injection during COVID-19 pandemic. Eye (Lond). 2020;34(7): 1165–1167. doi:10.1038/s41433-020-0925-x

46. Corradetti G, Corvi F, Nguyen TV, Sadda SR. Management of neovascular age-related macular degeneration during the COVID-19 pandemia. Ophthalmol Retina. 2020;S2468-6530(20): 30207-4. doi:10.1016/j.oret.2020.05.015

47. Yeung TLM, Liu S, Li BCY, Mok KM, Li KKW. Amniotic membrane harvesting during COVID-19 pandemic. Eye (Lond). 2020;1. doi:10.1038/s41433-020-0947-4

48. Veritti D, Sarao V, Bandello F, Lanzetta P. Infection control measures in ophthalmology during the COVID-19 outbreak: A narrative review from an early experience in Italy. Eur J Ophthalmol. 2020. doi:10.1177/1120672120927865

49. McPherson SW, Keunen JE, Bird AC, Chew EY, van Kuijk FJ. Investigate Oral Zinc as a Prophylactic Treatment for Those at Risk for COVID-19. Am J Ophthalmol. 2020;S0002-9394(20): 30213-0. doi:10.1016/j.ajo.2020.04.028

50. Speth RC, Carrera EJ, Jean-Baptiste M, Joachim A, Linares A. The concentration-dependent effects of zinc on angiotensin-converting enzyme 2 activity. FASEB J. 2014;28(1_supplement).

51. Skalny AV, Rink L, Ajsuvakova OP, Aschner M, Gritsenko VA, Alekseenko SI, Svistunov AA, Petrakis D, Spandidos DA, Aaseth J, Tsatsakis A, Tinkov AA. Zinc and respiratory tract infections: Perspectives for COVID‑19 (Review). International Journal of Molecular Medicine. 2020;46: 17–26. doi:10.3892/ijmm.2020.4575

52. Lauande R, Paula JS. Coronavirus and the eye: what is relevant so far? Arq Bras Oftalmol. 2020;83(3): V–VI. doi:10.5935/0004-2749.20200057

53. Tognetto D, Pastore MR, De Giacinto C, Cecchini P, Agolini R, Giglio R, Vinciguerra AL. Managing ophthalmic practices in a referral emergency COVID-19 hospital in north-east Italy. Acta Ophthalmol. 2020. doi:10.1111/aos.14488

54. Abramowicz JS, Basseal JM, Brezinka C, Dall’Asta A, Deng J, Harrison G, Lee JCS, Lim A, Maršal K, Miloro P, Poon LC, Salvesen KÅ, Sande R, Ter Haar G, Westerway SC, Xie MX, Lees C. ISUOG Safety Committee Position Statement on use of personal protective equipment and hazard mitigation in relation to SARS-CoV-2 for practitioners undertaking obstetric and gynecological ultrasound. Ultrasound Obstet Gynecol. 2020;55(6): 886–891. doi:10.1002/uog.22035

55. Chaurasia S, Sharma N, Das S. COVID-19 and eye banking. Indian J Ophthalmol. 2020;68(6): 1215–1216. doi:10.4103/ijo.IJO_1033_20

56. Bayyoud T, Iftner T, Bartz-Schmidt KU, Rohrbach JM, Ueffing M, Schindler M, Thaler S. Erste Ergebnisse zu Untersuchungen der menschlichen Hornhaut auf SARSCoV‑2- RNA [First results of investigations of SARS-CoV‑2 RNA in human corneal tissue]. Ophthalmologe. 2020;1-3. doi:10.1007/s00347-020-01151-0

57. Waikar S, Oli A. COVID-19: Ophthalmic prophylactic and therapeutic measures. Indian J Ophthalmol. 2020;68(6): 1223–1224. doi:10.4103/ijo.IJO_883_20

58. Shetty R, Lalgudi VG, Khamar P, Gupta K, Sethu S, Nair A, Honavar SG, Ghosh A, D’Souza S. Potential ocular and systemic COVID-19 prophylaxis approaches for healthcare professionals. Indian J Ophthalmol. 2020;68(7): 1349–1356. doi:10.4103/ijo.IJO_1589_20

59. Jeong A, Sagong M. Changes in the clinical practice of ophthalmology during the coronavirus disease 2019 (COVID-19) outbreak: an experience from Daegu, Korea. Infect Chemother. 2020.

60. Corazza P, D’Alterio FM, Younis S. Proposed algorithm during COVID-19 pandemic for patient management in medical retina clinic. Int J Retina Vitreous. 2020;6: 20. doi:10.1186/s40942-020-00226-z

61. Tan GSE, Linn KZ, Soon MML, Vasoo S, Chan M, Poh BF, Ng OT, Ang BS, Leo YS, Marimuthu K. Effect of extended use N95 respirators and eye protection on personal protective equipment (PPE) utilization during SARS-CoV-2 outbreak in Singapore. Antimicrob Resist Infect Control. 2020;9(1): 86. doi:10.1186/s13756-020-00753-2

62. Cheung SSL, Wong CYK, Chan JCK, Chan CKM, Lam NM, Yuen HKL, Wong VWY, Tsang CW, Tham CCY. Ophthalmology in the time of COVID-19: experience from Hong Kong Eye Hospital. Int J Ophthalmol. 2020;13(6): 851–859. doi:10.18240/ijo.2020.06.01

63. Société Française d’Ophtalmologie. Protection oculaire en réanimation (SFO-CNPO) pendant la période d’épidémie au Covid-19. J Fr Ophtalmol. 2020;43(6): 531–532. [Eye protection in intensive care (French Ophthalmology Society-National Council of Professionals in Ophthalmology) during COVID-19 pandemic. J Fr Ophtalmol. 2020;43 (6): 531–532. (In Fr.)] doi:10.1016/j.jfo.2020.04.010

64. Koh AHC, Koh LRS, Sheu SJ, Sakamoto T. What COVID-19 has taught us: lessons from around the globe. Graefes Arch Clin Exp Ophthalmol. 2020;1-4. doi:10.1007/s00417-020-04791-9

65. Teo KYC, Chan RVP, Cheung CMG. Keeping our eyecare providers and patients safe during the COVID-19 pandemic. Eye (Lond). 2020;34(7): 1161–1162. doi:10.1038/s41433-020-0960-7

66. Nair AG, Gandhi RA, Natarajan S. Effect of COVID-19 related lockdown on ophthalmic practice and patient care in India: Results of a survey. Indian J Ophthalmol. 2020;68(5): 725–730. doi:10.4103/ijo.IJO_797_20

67. Saedon H, Gould G, Begum M, Aslam TM. Video Conferencing in the Intravitreal Injection Clinic in Response to the COVID-19 Pandemic. Ophthalmol Ther. 2020;1-6. doi:10.1007/s40123-020-00262-w

68. Saleem SM, Pasquale LR, Sidoti PA, Tsai JC. Virtual Ophthalmology: Telemedicine in a COVID-19 Era. Am J Ophthalmol. 2020;S0002-9394(20): 30214-2. doi:10.1016/j.ajo.2020.04.029

69. Akkara JD, Kuriakose A. Commentary: Gamifying teleconsultation during COVID-19 lockdown. Indian J Ophthalmol. 2020;68(6): 1013–1014. doi:10.4103/ijo.IJO_1495_20